Molecular Imaging: Page 123

Digital FDG-PET offers insights into hearing loss

By Wayne Forrest

The use of digital PET to measure FDG uptake in the area of the brain devoted to hearing can help diagnose asymmetrical hearing loss and gauge the potential efficacy of a cochlear implant, according to a study published in the March issue of the Journal of Nuclear Medicine.

March 29, 2020

PSMA-PET/CT again shows prowess for prostate cancer

By Wayne Forrest

Prostate-specific membrane antigen (PMSA)-PET/CT could become the primary modality approach in confirming the extent of prostate cancer and the most efficient way to direct patients to the most appropriate treatment, according to a study published March 22 in the Lancet.

March 24, 2020

Navidea gets 5-year patent extension for Lymphoseek

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has received a five-year patent extension for its Lymphoseek radiopharmaceutical.

March 19, 2020

Cerveau partners with Alector on imaging agent

By AuntMinnie.com staff writers

Radiopharmaceutical developer Cerveau Technologies announced a licensing agreement with biotechnology company Alector for use of its MK-6240 investigational tau imaging agent for PET scans.

March 19, 2020

FDG-PET leads prediction on neuroendocrine tumor outcomes

By Wayne Forrest

FDG-PET has again proved its value by correlating positive neuroendocrine tumors in patients treated with peptide receptor radionuclide therapy (PRRT) to their chances of overall and progression-free survival, according to a study published March 13 in the Journal of Nuclear Medicine.

March 17, 2020

Blue Earth launches phase III trial for PET agent

By AuntMinnie.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics said that a phase III clinical trial of its investigational radiohybrid PET imaging agent for prostate cancer is now underway.

March 16, 2020

SNNMI still plans annual meeting -- for now

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has sent a note to its members that, as of today, the organization still plans to hold its annual meeting in New Orleans in June.

March 10, 2020

IMV: PET scan volume continues growing at steady pace

By Lorna Young

Procedure volume in the PET market is continuing to grow at about 6% per year in the U.S. since 2013, reaching its highest level ever in the U.S. in 2019, according to a new report by IMV Medical Information Division.

March 9, 2020

Framatome, Kinectrics partner on Lu-177

By AuntMinnie.com staff writers

French nuclear reactor firm Framatome and Toronto-based Kinectrics have launched a joint venture, called Isogen, to provide support for the production of the medical isotope lutetium-177 (Lu-177).

March 4, 2020

Choline-PET boosts mpMRI for prostate cancer detection

By Wayne Forrest

The addition of F-18 choline PET to multiparametric MRI (mpMRI) can significantly improve the detection of higher-risk primary prostate cancer and assessment of patients with suspected cases, according to a study published in the March issue of the Journal of Nuclear Medicine.

March 4, 2020

Korean researchers create isotope for cancer

By AuntMinnie.com staff writers

The Korea Atomic Energy Research Institute has developed the technology to produce the medical isotope copper-67 for simultaneous cancer diagnosis and treatment, according to a March 4 report in the Korean Times.

March 3, 2020

ASE publishes new guideline for congenital anomalies

By AuntMinnie.com staff writers

The American Society of Echocardiography (ASE) has published new recommendations for multimodality assessment of congenital coronary anomalies.

March 2, 2020

Previous Page

Page 123 of 614

Next Page